AERSMine

A new online open-access database has been developed by scientists to allow the clinical responses of more than 5 million patients to all FDA-approved drugs to be used to identify unexpected clinical harm, benefits and alternative treatment choices for individual patients, according to a study appearing July 8 in Nature Biotechnology. Developed by scientists in the Division of Biomedical Informatics and the Clinical and Translational Sciences Program at Cincinnati Children's Hospital Medical Center, the database has the potential to help reduce negative side effects from prescription drugs and identify opportunities to reposition existing drugs for new uses, report the study's authors.

Read More »